These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3037163)

  • 21. Captopril for hypertension.
    Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
    Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V
    J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible new role for angiotensin-converting enzyme inhibitors in treating glomerulonephritis.
    Soliman AR; el-Meligi AA; el-Semari M; el-Shemi N; Mahmoud H
    East Mediterr Health J; 2003 May; 9(3):399-406. PubMed ID: 15751933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranous glomerulopathy in a patient on captopril.
    Hoorntje SJ; Donker AJ; Prins EJ; Weening JJ
    Acta Med Scand; 1980; 208(4):325-9. PubMed ID: 7004096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of captopril and hydrochlorothiazide on glomerular haemodynamics and histological damage in Goldblatt hypertension with partial renal ablation.
    Herrera-Acosta J; Gabbai FB; Tapia E; Cermeño JL; Calleja C; Bobadilla NA; Romero L
    J Hypertens Suppl; 1986 Dec; 4(5):S275-8. PubMed ID: 3553476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril - a genuine innovation.
    Drug Ther Bull; 1982 Feb; 20(4):13-5. PubMed ID: 6277587
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membranous glomerulopathy and nephrotic syndrome after captopril therapy.
    Sturgill BC; Shearlock KT
    JAMA; 1983 Nov; 250(17):2343-5. PubMed ID: 6355523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 36. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
    Lindsjö M; Danielson BG; Weiss L; Wikström B
    Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive agents: a new angiotensin converting enzyme inhibitor: captopril.
    Romankiewicz JA
    J Pract Nurs; 1982 Apr; 32(4):9-11. PubMed ID: 7042961
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.